Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.32%
SPX
+0.24%
IXIC
+0.21%
FTSE
+0.04%
N225
+0.73%
AXJO
+0.22%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Overview

Loading chart...
Join our newsletter to keep up to date with us!

Key Stats

Market Cap
19.98B
Dividend Yield
0.00%
P/E Ratio
13.05
EPS
11.22
Revenue
9.68B
Avg. Volume
1.22M

Recently from Cashu

publisher logo
Cashu

Biogen's Industry Response: JNJ Invests $2 Billion in U.S. Manufacturing Amid Regulatory Changes

3 days ago
publisher logo
Cashu

Biogen's Cup-and-Handle Pattern Signals Potential Rebound Despite Historical Caution

5 days ago
publisher logo
Cashu

Biogen's Stock Shows Signs of Recovery Amid Technical Breakout Potential

7 days ago

About

What does BIIB do?
Biogen, headquartered in Cambridge, Massachusetts, specializes in therapies for neurological diseases, employing 7,570 people and offering treatments for conditions like MS, SMA, Alzheimer's, and ALS. Their product portfolio includes TECFIDERA, SPINRAZA, and collaborations on LEQEMBI and others.
Sector
💻 Health Care
IPO
CEO
Employees
7,605
Headquarters
Massachusetts, USA
Website
http://www.biogen.com
Stocks
Health Care
biib
Biogen
NASDAQ: BIIB
-0.43 (-0.31%)
136.29
USD
At close at Aug 27, 20:33 UTC
Summary
News
Signals
Benchmarks
Financials